Clinical Effectiveness of the Recombinant Zoster Vaccine for Preventing Herpes Zoster in Individuals With Kidney Transplants: A Retrospective Cohort Study.
BACKGROUND People who have received kidney transplants (KTs) are at increased risk for herpes zoster (HZ). The recombinant zoster vaccine (RZV) is recommended for immunocompromised individuals based on immunogenicity data, including studies in solid organ transplant populations. However, evidence on its real-world effe...